Paper · 2026 · Open access
Drug Discovery: From Target Identification to AI-Powered Screening
Zenodo (CERN European Organization for Nuclear Research) · Published 24 February 2026 · DOI 10.5281/zenodo.18763154
In brief
“Drug Discovery: From Target Identification to AI-Powered Screening” is a 2026 paper by Sneha V Sanjanavathi N*, published in Zenodo (CERN European Organization for Nuclear Research). OpenAlex counts 0 citations as of 15 November 2026. It is open access under a CC BY licence: the full text is free to read at Zenodo (CERN European Organization for Nuclear Research).
- Citations
- 0
- Authors
- 1
Abstract
Artificial intelligence (AI) is transforming traditional drug development by enabling faster, cost-effective, and more accurate discovery processes. AI-based technologies such as machine learning, deep learning, and predictive modelling help identify drug targets, screen compounds, and optimize lead molecules with greater precision. By analysing large datasets and uncovering patterns often missed by conventional methods, AI minimizes research timelines, reduces development failures, and improves decision-making across preclinical and clinical stages. This review summarizes the major applications, benefits, and future potential of AI in modern drug discovery and development.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
N*, S. V. S. (2026). Drug Discovery: From Target Identification to AI-Powered Screening. Zenodo (CERN European Organization for Nuclear Research). https://doi.org/10.5281/zenodo.18763154
MLA 9
N*, Sneha V Sanjanavathi. “Drug Discovery: From Target Identification to AI-Powered Screening.” Zenodo (CERN European Organization for Nuclear Research), 2026. https://doi.org/10.5281/zenodo.18763154.
Chicago
N*, Sneha V Sanjanavathi. 2026. “Drug Discovery: From Target Identification to AI-Powered Screening.” Zenodo (CERN European Organization for Nuclear Research). https://doi.org/10.5281/zenodo.18763154.
Harvard
N*, S. V. S. (2026) ‘Drug Discovery: From Target Identification to AI-Powered Screening’, Zenodo (CERN European Organization for Nuclear Research). doi:10.5281/zenodo.18763154.
IEEE
S. V. S. N*, “Drug Discovery: From Target Identification to AI-Powered Screening,” Zenodo (CERN European Organization for Nuclear Research), 2026, doi: 10.5281/zenodo.18763154.
BibTeX
@article{n2026drug,
title = {{Drug Discovery: From Target Identification to AI-Powered Screening}},
author = {N*, Sneha V Sanjanavathi},
journal = {Zenodo (CERN European Organization for Nuclear Research)},
year = {2026},
doi = {10.5281/zenodo.18763154},
url = {https://doi.org/10.5281/zenodo.18763154}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- artificial intelligence in drug discovery
- drug target identification
- machine learning
- deep learning
- predictive modeling
- lead optimization
- preclinical drug development
- clinical development
Work with this paper
Most-cited papers in Pharmacology, Toxicology and Pharmaceutics
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingOleg Trott, Arthur J. Olson · Journal of Computational Chemistry · 2009 · 39,860 citations
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibilityGarrett M. Morris, Ruth Huey, William Lindstrom and 4 more · Journal of Computational Chemistry · 2009 · 26,508 citations
- Development and testing of a general amber force fieldJunmei Wang, Romain M. Wolf, James W. Caldwell and 2 more · Journal of Computational Chemistry · 2004 · 20,080 citations
- Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1Christopher A. Lipinski, Franco Lombardo, Beryl W. Dominy and 1 more · Advanced Drug Delivery Reviews · 2001 · 19,638 citations
- SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small moleculesAntoine Daina, Olivier Alain Michielin, Vincent Zoete · Scientific Reports · 2017 · 19,557 citations
All highly cited Pharmacology, Toxicology and Pharmaceutics papers
Questions about this paper
How do I cite this paper in APA style?
N*, S. V. S. (2026). Drug Discovery: From Target Identification to AI-Powered Screening. Zenodo (CERN European Organization for Nuclear Research). https://doi.org/10.5281/zenodo.18763154
How many times has this paper been cited?
0 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access: read the free full text at Zenodo (CERN European Organization for Nuclear Research).
Who wrote this paper?
Sneha V Sanjanavathi N*.
What is the DOI of this paper?
10.5281/zenodo.18763154. The permanent link is https://doi.org/10.5281/zenodo.18763154.
Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.